Another study showed that a specific SLC26A2-STAS mutation associated with the skeletal disease, diastrophic dysplasia, impairs SLC26A2 trafficking to the plasma membrane (Rapp et al., 2017). The gene discussed is SLC26A2; the disease is diastrophic dysplasia.